|
Ä«Å×°í¸®
|
ÀǾàǰ
|
|
Á¦¸ñ
|
[½ÄǰÀǾàǰ¾ÈÀüó] µ¿µî»ý¹°ÀǾàǰ Æò°¡ °¡À̵å¶óÀÎ ¿µ¹®ÆÇ(¹Î¿øÀξȳ»¼)
|
|
ÀÛ¼ºÀÚ
|
kbihealth
|
|
µî·ÏÀÏ
|
2024-11-13
|
|
Á¶È¸¼ö
|
153
|
½ÄǰÀǾàǰ¾ÈÀüó¿¡¼´Â µ¿µî»ý¹°ÀǾàǰ Æò°¡ °¡À̵å¶óÀÎ ¿µ¹®ÆÇ(¹Î¿øÀξȳ»¼)/ Biosimilar Product Evaluation GuidelineÀ» ¹ß°£ÇÏ¿´À¸´Ï °ü·Ã ¾÷¹«¿¡ Âü°íÇϽñ⠹ٶø´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
|
|
÷ºÎÆÄÀÏ
|
µ¿µî»ý¹°ÀǾàǰ Æò°¡ °¡À̵å¶óÀÎ ¿µ¹®ÆÇ(¹Î¿øÀξȳ»¼).pdf

´Ù¿î·Îµå : 195
|